The results exhibited that the sensitivity of cancer cells to paclitaxel-induced cytotoxicity, apoptosis, and cell-cycle arrest was enhanced obviously by S100A6, which is similar to the growth inhibitory activity. Here, S100A6 is linked to cancer.